There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize ...

Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...

Dr Arshad Khanani anticipates presentations offering new strategies to tackle challenges such as macular atrophy and fibrosis, and optimizing dosing intervals in wet AMD.

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including ...

Brain-computer interface (BCI) developer Science Corporation today announced preliminary clinical trial results for its Prima ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Dry AMD is more common, accounting for about 80–90% of cases. It occurs when the macula, the part of the retina responsible for central vision, gradually thins with age, leading to the ...